Janus Henderson Group PLC Argenx Se Transaction History
Janus Henderson Group PLC
- $207 Billion
- Q3 2025
A detailed history of Janus Henderson Group PLC transactions in Argenx Se stock. As of the latest transaction made, Janus Henderson Group PLC holds 2,575,251 shares of ARGX stock, worth $2.34 Billion. This represents 0.92% of its overall portfolio holdings.
Number of Shares
2,575,251
Previous 2,565,399
0.38%
Holding current value
$2.34 Billion
Previous $1.41 Billion
34.32%
% of portfolio
0.92%
Previous 0.73%
Shares
32 transactions
Others Institutions Holding ARGX
# of Institutions
526Shares Held
26MCall Options Held
590KPut Options Held
320K-
Price T Rowe Associates Inc Baltimore, MD3.64MShares$3.31 Billion0.29% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.19MShares$1.99 Billion2.46% of portfolio
-
Capital World Investors Los Angeles, CA1.96MShares$1.78 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY1.01MShares$918 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY990KShares$899 Million9.98% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $50.2B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...